Correlation between Serum Insulin and Features of Metabolic Syndrome in Thais

Journal of the Medical Association of Thailand

Volumn 83, Issue 7, 2000, Pages 783-789

  Bunnag, Pongamorn ^a   Chanprasertyothin, Suwannee ^a   Kongsuksai, Atana ^a   Ongphiphadhanakul, Boonsong ^a   Rajatanavin, Rajata ^a   Puavilai, Gobchai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Atherosclerosis; HOMA S; Insulin Resistance; Metabolic Syndrome

Indexed keywords

INSULIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; INCIDENCE; INSULIN RESISTANCE; MALE; MIDDLE AGED; PHYSIOLOGY; RISK FACTOR; THAILAND;

ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENCE; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK FACTORS; THAILAND;

EID: 0034221648     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
2. Stern MP. The insulin resistance syndrome.In: Alberti KGMM, Zimmet P, Defronzo RA, Keen H, eds. International Textbook of Diabetes Mellitus. London: John Wiley & Sons, 1997: 255-83.
3. Modan J, Halkin H, Almog S, et al. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. Hypertension 1985;75:809-17.
4. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
5. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997;20:1087-92.
6. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
7. Fujioka S, Matsuzawa Y, Tokinaga K, et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987;36:54-9.
8. Abate N. Insulin resistance and obesity: the role of fat distribution pattern. Diabetes Care 1996;19: 292-4.
9. Garg A. Insulin resistance in the pathogenesis of dyslipidemia. Diabetes Care 1996;4:387-9.
10. Ferannini E, Barrett EJ, Bevilacqua S, et al. Effects of fatty acids on glucose production and utilization in man. J Clin Invest 1983;72:1737-47.
11. Groop LC, Saloranta C, Shank M, et al. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1991;72:96-107.
12. Donahue RP, Prineas RJ, Donahue RD, et al. Is fasting leptin associated with insulin resistance among nondiabetic individuals? Diabetes Care 1999;22:1092-6.
13. Ferannini E, Buzzigoli G, Bonadona R, et al. Insulin resistance in essential hypertension. N Eng J Med 1987;317:350-7.
14. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990;39:167-74.
15. Collins VR, Dowse GK, Finch CF, et al. An inconsistent relationship between insulin and blood pressure in three Pacific Island populations. J Clin Epidemiol 1990;43:1369-78.
16. Saad MF, Lillioja S, Nyomba BL, et al. Racial differences in the relation between blood pressure and insulin resistance. N Eng J Med 1991; 324:733-9.
17. Miura K, Nakagawa H, Nishijo M, et al. Plasma insulin and blood pressure in normotensive Japanese men with normal glucose tolerance. J Hypertens 1995;13:427-32.
18. Asch S, Wingrad DL, Barrett-Conner EL. Are insulin and hypertension independently related? Ann Epidemiol 1991;1:231-44.
19. Denker PS. Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch Intern Med 1992;152:1649-51.
20. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979;2.131-41.
21. Pyorala K, Savolainen E, Kaukola S, et al. Plasma insulin as coronary disease risk factor: relationship to other risk factors and predictive value during 9 1/2 year follow-up of the Helsinki Policeman study population. Acta Med scand 1985;701 (suppl):38-52.
22. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton in reference to glucose and insulin concentrations. Diabetes 1979;2:154-60.
23. Ducimetiere P, Eschwege E, papoz L, et al. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980;19:205-10.
24. Fontbonne A, Charles MA, Thibult N, et al. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, a 15-year follow up. Daibetologia 1991;34:356-61.
25. Despres J-P, Lamarge B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Eng J Med 1996; 334:952-7.
26. Hargreaves AD, Logan RL, Elton RA, et al. Glucose tolerance, plasma insulin, HDL-cholesterol and obesity; 12-year follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis 1992;94:61-9.
27. Welin L, Eriksson H, Larsson B, et al. Hyperinsulinemia is not a major coronary risk factor in elderly men: the study of men born in 1913. Diabetologia 1992;35:766-72.
28. Ferrara A, Barrett-Conner E, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernado Study, J Med Assoc Thai 2000; 83: 790-796